mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.1 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.1 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.1 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
CGP-082996 |
GDSC1000 |
pan-cancer |
AAC |
-0.077 |
0.1 |